Drug Trials Snapshots: LUTATHERA

For the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Source: FDA Center for Drug Evaluation and Research - What's New - March 19, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news